Recent

% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • ajthedrifter ajthedrifter Mar 13, 2012 1:32 PM Flag

    any hope for a potential halt?

    The potential for early trial end and fast track for approval is a possibility. If phase 2 data matches phase 1 or is even remotely close, the FDA cannot ignore it.

    IMUC has a few more cancer treatment candidates in the works. This company has huge upside.

 
IMUC
0.4834+0.0034(+0.71%)May 29 4:00 PMEDT